Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now later-stage tilt

Paroxysmal Atrial Fibrillation: later-stage trial registry

9 of 25 indexed Paroxysmal Atrial Fibrillation trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #652 of 28,707 conditions by registered trial count.

25 US clinical trials · 9 currently recruiting · #652 of 28,707 conditions by registered trial count

Paroxysmal Atrial Fibrillation: 25 US clinical trials tracked, 9 recruiting.

Paroxysmal Atrial Fibrillation is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Boston Scientific Corporation, running 5 of these trials.

Enrollment posture brief

Registry condition paroxysmal-atrial-fibrillation

OPEN 9 | RECR 36% | LATE 4 | EARLY 1 | RANK #652 | SPON 5

Nearest open-share peer: Cannabis (36% recruiting · 25 trials)

Alpha-1 Antitrypsin Deficien48%Alcohol Use40%Acute Lymphocytic Leukemia36%Alcohol-Related Disorders36%Paroxysmal Atrial Fibril (th…36%
Open-enrollment share among volume-matched conditions near Paroxysmal Atrial Fibrillation

Paroxysmal Atrial Fibrillation lists 9 open slots (36% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Paroxysmal Atrial Fibrillation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Paroxysmal Atrial Fibrillation is recruiting below its size-band peers.

    9 of 25 indexed trials (36%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Paroxysmal Atrial Fibrillation research.

    Boston Scientific Corporation accounts for 5 of 25 trials (20%). 16 distinct sponsors appear on at least one study for this condition label.

  3. Typical Paroxysmal Atrial Fibrillation enrolment sits around 228 participants.

    Median target enrolment is 228 among the 25 trials that report a genuine target (sentinel values excluded). 4 of those (16%) plan for fewer than 100 participants.

  4. Paroxysmal Atrial Fibrillation splits between interventional and observational designs.

    15 interventional and 10 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 31Phase 43

Open and recent trials

25 total, page 1 of 1

RECRUITING 15,000 participants

Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Heart Rhythm Clinical and Research Solutions

NCT04088071

RECRUITING Phase 4 275 participants

Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias

Vivek Reddy

NCT06765356

RECRUITING NA 250 participants

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

Vivek Reddy

NCT05988411

RECRUITING 250 participants

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Heart Rhythm Clinical and Research Solutions

NCT06324201

RECRUITING 200 participants

STOP AF First Post-Approval Study

Medtronic Cardiac Ablation Solutions

NCT05227053

RECRUITING NA 200 participants

POLARx Post Approval Study (POLARx PAS)

Boston Scientific Corporation

NCT06170606

RECRUITING NA 160 participants

Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)

University of Oklahoma

NCT05172765

RECRUITING 50 participants

Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)

Northwell Health

NCT07344961

RECRUITING 50 participants

EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation

Virginia Commonwealth University

NCT06212791

ACTIVE NOT RECRUITING NA 549 participants

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Kardium

NCT05462145

ACTIVE NOT RECRUITING 228 participants

ADVENT Post Approval Study

Boston Scientific Corporation

NCT06431815

ACTIVE NOT RECRUITING NA 128 participants

Treatment of PAF With the Synaptic System

Synaptic Medical Corporation

NCT05905835

ACTIVE NOT RECRUITING NA 50 participants

Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)

Stanford University

NCT03834844

ACTIVE NOT RECRUITING 49 participants

RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation

The Cleveland Clinic

NCT04835844

COMPLETED NA 706 participants

The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation

Boston Scientific Corporation

NCT04612244

COMPLETED 364 participants

ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

Boston Scientific Corporation

NCT06526546

COMPLETED NA 355 participants

TactiFlex Paroxysmal Atrial Fibrillation IDE Trial

Abbott Medical Devices

NCT04356040

COMPLETED Phase 4 333 participants

Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)

Biosense Webster

NCT03624881

COMPLETED NA 321 participants

Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation

Boston Scientific Corporation

NCT04580914

COMPLETED 320 participants

Cryoballoon PVI With PWI Versus PVI Alone In Patients With PAF

Sacramento EP Research

NCT05296824

COMPLETED Phase 3 245 participants

A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation

Medtronic Cardiac Rhythm and Heart Failure

NCT00523978

COMPLETED NA 178 participants

TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study

Abbott Medical Devices

NCT02310100

COMPLETED 143 participants

LSI (Lesion Index) Workflow Observational Study

Abbott Medical Devices

NCT03906461

COMPLETED Phase 4 112 participants

A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

Biosense Webster

NCT00540787

COMPLETED Phase 2 100 participants

Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

CardioFocus

NCT00971204

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1
Phase 4 3

Named interventions

Most-linked intervention names on Paroxysmal Atrial Fibrillation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cryoballoon ablation for the treatment of atrial fibrillation Procedure
1 trials
TactiFlex SE - High Standard Power Device
1 trials
TactiFlex SE Device
1 trials
RadioFrequency and Cryoballoon Ablation Device
1 trials
FARAPULSE Pulsed Field Ablation System Device
1 trials
Treatment with IntellaNav StablePoint Ablation Catheter Device
1 trials
CardioFocus HeartLight Endoscopic Ablation System Device
1 trials
TactiCath Quartz treatment Device
1 trials

US sites by state

Facility locations filed on Paroxysmal Atrial Fibrillation trials. A trial with sites in several states counts in each.

California 17 trials
New York 14 trials
Florida 11 trials
Alabama 11 trials
Massachusetts 10 trials
Texas 9 trials
Pennsylvania 9 trials
Ohio 9 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Paroxysmal Atrial Fibrillation page

25 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Paroxysmal Atrial Fibrillation condition card totals 25 registered trials; most-linked intervention Cryoballoon ablation for the treatment of atrial fibrillation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.